Study protocol of a randomised controlled trial of prostate radiotherapy in high-risk and node-positive disease comparing moderate and extreme hypofractionation (PRIME TRIAL)

INTRODUCTION: There has been an interest in studying the efficacy of extreme hypofractionation in low and intermediate risk prostate cancer utilising the low alpha/beta ratio of prostate. Its role in high-risk and node-positive prostate cancer, however, is unknown. We hypothesise that a five-fractio...

Descripción completa

Detalles Bibliográficos
Autores principales: Murthy, Vedang, Mallick, Indranil, Gavarraju, Abhilash, Sinha, Shwetabh, Krishnatry, Rahul, Telkhade, Tejshri, Moses, Arunsingh, Kannan, Sadhna, Prakash, Gagan, Pal, Mahendra, Menon, Santosh, Popat, Palak, Rangarajan, Venkatesh, Agarwal, Archi, Kulkarni, Sheetal, Bakshi, Ganesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050316/
https://www.ncbi.nlm.nih.gov/pubmed/32114475
http://dx.doi.org/10.1136/bmjopen-2019-034623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050316/
https://www.ncbi.nlm.nih.gov/pubmed/32114475
http://dx.doi.org/10.1136/bmjopen-2019-034623

Ejemplares similares